X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (71767) 71767
Book Review (10680) 10680
Newsletter (8838) 8838
Publication (3969) 3969
Book Chapter (539) 539
Conference Proceeding (469) 469
Newspaper Article (243) 243
Magazine Article (189) 189
Dissertation (182) 182
Book / eBook (95) 95
Web Resource (39) 39
Trade Publication Article (21) 21
Paper (17) 17
Journal / eJournal (14) 14
Reference (11) 11
Government Document (8) 8
Transcript (3) 3
Data Set (2) 2
Streaming Video (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51971) 51971
humans (43388) 43388
male (29352) 29352
female (24175) 24175
nephropathy (20326) 20326
middle aged (17713) 17713
urology & nephrology (16608) 16608
diabetic nephropathies (16064) 16064
adult (15765) 15765
animals (14505) 14505
diabetes (11793) 11793
aged (10923) 10923
diabetic nephropathy (10591) 10591
research (9041) 9041
risk factors (8465) 8465
rats (7782) 7782
kidney diseases (7224) 7224
endocrinology & metabolism (6841) 6841
disease (6117) 6117
hypertension (5959) 5959
transplantation (5880) 5880
proteinuria (5720) 5720
iga nephropathy (5482) 5482
mice (5314) 5314
diabetes mellitus (5239) 5239
kidney - pathology (5155) 5155
adolescent (5018) 5018
nephrology (4903) 4903
kidneys (4842) 4842
diabetic-nephropathy (4766) 4766
analysis (4685) 4685
kidney (4664) 4664
diabetic nephropathies - physiopathology (4563) 4563
medicine, general & internal (4554) 4554
expression (4538) 4538
oxidative stress (4488) 4488
glomerular filtration rate (4416) 4416
type 2 diabetes (4300) 4300
mellitus (4216) 4216
abridged index medicus (4078) 4078
care and treatment (3892) 3892
diabetes mellitus, type 2 - complications (3822) 3822
progression (3809) 3809
medical research (3783) 3783
time factors (3758) 3758
disease progression (3708) 3708
kidney transplantation (3677) 3677
reports (3661) 3661
treatment outcome (3599) 3599
microalbuminuria (3535) 3535
diabetic nephropathies - metabolism (3515) 3515
albuminuria (3498) 3498
child (3470) 3470
diabetic nephropathies - pathology (3470) 3470
risk (3466) 3466
mortality (3460) 3460
development and progression (3386) 3386
glomerulonephritis (3368) 3368
medicine, experimental (3359) 3359
chronic kidney failure (3336) 3336
health aspects (3302) 3302
prognosis (3299) 3299
retrospective studies (3279) 3279
blood pressure (3258) 3258
prevalence (3236) 3236
biopsy (3231) 3231
diabetic nephropathies - drug therapy (3224) 3224
fibrosis (3196) 3196
diabetic nephropathies - etiology (3143) 3143
inflammation (3141) 3141
creatinine - blood (3115) 3115
medicine & public health (3106) 3106
pharmacology & pharmacy (3097) 3097
follow-up studies (3096) 3096
medicine, research & experimental (3040) 3040
immunology (2968) 2968
complications (2963) 2963
diabetic nephropathies - complications (2912) 2912
glucose (2880) 2880
rodents (2877) 2877
surgery (2876) 2876
kidney - metabolism (2874) 2874
kidney - drug effects (2841) 2841
proteins (2818) 2818
chronic kidney disease (2692) 2692
diabetic nephropathies - therapy (2641) 2641
peripheral vascular disease (2629) 2629
chronic kidney-disease (2599) 2599
diabetic nephropathies - blood (2568) 2568
blood-pressure (2567) 2567
kidney - physiopathology (2557) 2557
prospective studies (2513) 2513
diabetes mellitus, type 1 - complications (2478) 2478
prevention (2472) 2472
diabetics (2458) 2458
nephrotic syndrome (2436) 2436
diabetic nephropathies - prevention & control (2394) 2394
apoptosis (2375) 2375
disease models, animal (2375) 2375
diagnosis (2355) 2355
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (42) 42
Online Resources - Online (25) 25
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
St. Michael's Hospital - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Gerstein Science - Bindery (2) 2
Gerstein Science - Periodical Stacks (2) 2
Humber River Regional Hospital - Church Stacks (2) 2
Scarborough Hospital - Birchmount (2) 2
Scarborough Hospital - General (2) 2
Credit Valley Hospital - Reference (1) 1
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Theses (1) 1
Humber River Regional Hospital - Church Reference (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Grace (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
Toronto East General Hospital - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (75302) 75302
German (1146) 1146
Japanese (951) 951
French (904) 904
Spanish (841) 841
Russian (544) 544
Chinese (516) 516
Korean (445) 445
Polish (341) 341
Czech (184) 184
Italian (159) 159
Portuguese (159) 159
Hungarian (90) 90
Turkish (60) 60
Slovak (54) 54
Bulgarian (49) 49
Serbian (48) 48
Croatian (46) 46
Finnish (24) 24
Danish (21) 21
Persian (20) 20
Hebrew (18) 18
Dutch (17) 17
Swedish (17) 17
Romanian (12) 12
Ukrainian (12) 12
Bosnian (6) 6
Norwegian (4) 4
Slovenian (4) 4
Arabic (2) 2
Greek (2) 2
Catalan (1) 1
Icelandic (1) 1
Indonesian (1) 1
Lithuanian (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Kidney International, ISSN 0085-2538, 03/2012, Volume 81, Issue 6, pp. 559 - 567
Endemic (Balkan) nephropathy is a chronic tubulointerstitial disease frequently accompanied by urothelial cell carcinomas of the upper urinary tract. This... 
upper urinary tract cancer | endemic nephropathy | DNA adducts | Aristolochia | nephrotoxicity | aristolochic acid | ETIOLOGY | UPPER URINARY-TRACT | CHINESE HERBS NEPHROPATHY | OCHRATOXIN-A | GENOTOXICITY | BALKAN ENDEMIC NEPHROPATHY | DISEASE | CANCER-RISK | UROLOGY & NEPHROLOGY | KIDNEY | RISK-ASSESSMENT | Urologic Neoplasms - epidemiology | Humans | Middle Aged | Balkan Nephropathy - chemically induced | Male | DNA Adducts - analysis | DNA Mutational Analysis | Croatia - epidemiology | Aged, 80 and over | Balkan Nephropathy - genetics | Genetic Predisposition to Disease | Risk Assessment | Balkan Nephropathy - metabolism | Risk Factors | Biomarkers - analysis | Environmental Monitoring - methods | Urologic Neoplasms - chemically induced | Environmental Exposure | Bosnia and Herzegovina - epidemiology | Aristolochic Acids - adverse effects | Diet | Epidemiological Monitoring | Molecular Epidemiology | Carcinoma - genetics | Mutation | Carcinogens, Environmental - metabolism | Balkan Nephropathy - epidemiology | Kidney Cortex - drug effects | Residence Characteristics | Urologic Neoplasms - diagnosis | Case-Control Studies | Tumor Suppressor Protein p53 - genetics | Urologic Neoplasms - genetics | Biotransformation | Carcinoma - epidemiology | Mass Spectrometry | Carcinogens, Environmental - adverse effects | Adult | Female | Urologic Neoplasms - metabolism | Carcinoma - chemically induced | Carcinoma - diagnosis | Kidney Cortex - pathology | Aristolochic Acids - metabolism | Kidney Cortex - chemistry | Aged | Balkan Nephropathy - diagnosis | Carcinoma - metabolism | Serbia - epidemiology | Urine | renal cortex | Carcinoma | biomarkers | Mass spectroscopy | Aristolochic acid | Urinary tract | urothelium | Kidney | p53 protein | Diets | Carcinogens | Nephropathy | urothelial carcinoma | DNA | Metabolic activation | genomics | Bioindicators | Mass spectrometry | Adducts | Tumors | Index Medicus
Journal Article
Journal Article
1999, Contributions to nephrology, ISBN 3805568339, Volume 126., ix, 115
It is clear that IgA nephropathy is one of the most common types of chronic glomerulonephritis in the world. It is also recognized that this disease is the... 
IgA glomerulonephritis
Book
2009, ISBN 9789812835864, xx, 419
Book
Scientific reports, ISSN 2045-2322, 05/2019, Volume 9, Issue 1, pp. 7185 - 2
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper. 
Nephropathy
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2453 - 2453
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 08/2018, Volume 36, Issue 23, pp. 2454 - 2454
Journal Article
Toxicology and Applied Pharmacology, ISSN 0041-008X, 12/2012, Volume 265, Issue 3, pp. 360 - 367
Aristolochic acid causes a specific nephropathy (AAN), Balkan endemic nephropathy, and urothelial malignancies. Using Western blotting suitable to determine... 
Mouse models | Metabolic activation | Protein expression | NAD(P):quinone oxidoreductase | DNA adducts | Balkan endemic nephropathy | Aristolochic acid nephropathy | Aristolochic acid nephropathy$Balkan endemic nephropathy$NAD(P):quinone oxidoreductase$Protein expression$Metabolic activation$DNA adducts$Mouse models | UROTHELIAL CANCER | NAD(P)H-QUINONE OXIDOREDUCTASE-1 | ARISTOLACTAM-DNA ADDUCTS | METABOLIC-ACTIVATION | CYTOCHROMES P450 1A1 | CHINESE HERBS NEPHROPATHY | ARYL-HYDROCARBON RECEPTOR | GENE-EXPRESSION | ENVIRONMENTAL CARCINOGEN | PHARMACOLOGY & PHARMACY | TOXICOLOGY | Cytochrome P-450 CYP1A1 - genetics | Liver - enzymology | Humans | DNA Adducts - metabolism | Cytosol - enzymology | Aristolochic Acids - pharmacokinetics | Liver - drug effects | Cytochrome P-450 CYP1A2 - genetics | Cytochrome P-450 CYP1A2 - deficiency | Female | Cytochrome P-450 CYP1A1 - deficiency | Aristolochic Acids - toxicity | Cell Line | Balkan Nephropathy - genetics | Balkan Nephropathy - metabolism | Liver - metabolism | Mice, Inbred C57BL | Mice, Transgenic | Cytochrome P-450 CYP1A1 - metabolism | Cytochrome P-450 CYP1A2 - metabolism | Blotting, Western | Mice, Knockout | NAD(P)H Dehydrogenase (Quinone) - biosynthesis | Animals | Balkan Nephropathy - enzymology | NAD(P)H Dehydrogenase (Quinone) - metabolism | Cytosol - metabolism | Mice | Index Medicus | Enzymes | Cytochrome P450 | Liver | Lung | Genotoxicity | Transgenic mice | Aristolochic acid | Malignancy | CYP1A2 protein | Kidney | Western blotting | NAD(P)H:quinone oxidoreductase | Carcinogens | Nephropathy | DNA | NAD(P)H dehydrogenase (quinone) | Adducts | SULFATES | HYDROCARBONS | CARCINOGENS | METABOLIC ACTIVATION | THIN-LAYER CHROMATOGRAPHY | BENZOQUINONES | 60 APPLIED LIFE SCIENCES | ECR HEATING | DNA ADDUCTS | KIDNEYS | NAD | OXYGEN | URINARY TRACT | ENZYMES | LIVER | CARCINOMAS | RECEPTORS | TRANSGENIC MICE
Journal Article
Journal Article
2014, ISBN 9781493907939
Web Resource
Journal of Cellular Physiology, ISSN 0021-9541, 10/2017, Volume 232, Issue 10, pp. 2776 - 2787
Our findings provide new insights into the pathogenic process of HG‐induced podocyte injury and also identify a new therapeutic target of... 
dynamin‐related protein 1 | polydatin | diabetic nephropathy | dynamin-related protein 1 | APOPTOSIS | OXIDATIVE STRESS | ACTIVATION | PHYSIOLOGY | DIABETIC-NEPHROPATHY | DEFICIENCY | CELL-DEATH | CELL BIOLOGY | PATHOGENESIS | MICE | FISSION | DYSFUNCTION | Dynamins - metabolism | Reactive Oxygen Species - metabolism | Apoptosis - drug effects | Diabetic Nephropathies - etiology | Diabetic Nephropathies - drug therapy | Diabetes Mellitus, Type 2 - metabolism | Stilbenes - pharmacology | Transfection | RNA Interference | Diabetes Mellitus, Type 2 - complications | Cytoprotection | Disease Models, Animal | Cell Line | Diabetic Nephropathies - pathology | Glucosides - pharmacology | Podocytes - metabolism | Diabetic Nephropathies - metabolism | Down-Regulation | Mice, Inbred C57BL | Dynamins - genetics | Mitochondria - metabolism | Mitochondria - drug effects | Mitochondria - pathology | Podocytes - pathology | Animals | Mitochondrial Dynamics - drug effects | Podocytes - drug effects | Signal Transduction - drug effects | Diabetes Mellitus, Type 2 - pathology | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Hyperglycemia | Analysis | Diabetic nephropathies | Retarding | Mitochondria | Renal function | Nephropathy | Diabetes mellitus | Rodents | Resveratrol | Dynamin | Apoptosis | Fitness | Index Medicus | Original | Original s
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2017, Volume 377, Issue 9, pp. 839 - 848
In a randomized, controlled trial, liraglutide (a glucagon-like peptide 1 receptor agonist) or placebo was added to usual care in patients with type 2... 
MORTALITY | MEDICINE, GENERAL & INTERNAL | CARDIOVASCULAR OUTCOMES | ALBUMINURIA | INTENSIVE GLUCOSE CONTROL | KIDNEY-FUNCTION | DISEASE | RISK | DEATH | NEPHROPATHY | Hypoglycemic Agents - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Follow-Up Studies | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Male | Albuminuria - prevention & control | Acute Kidney Injury - prevention & control | Diabetic Nephropathies - mortality | Kidney Failure, Chronic - prevention & control | Glucagon-Like Peptide 1 - agonists | Liraglutide - adverse effects | Liraglutide - therapeutic use | Intention to Treat Analysis | Creatinine - blood | Female | Aged | Diabetes Mellitus, Type 2 - drug therapy | Diabetic Nephropathies - prevention & control | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Care and treatment | Usage | Analysis | Diabetic nephropathies | Outcome and process assessment (Health Care) | Research | Liraglutide | Myocardial infarction | Creatinine | Cerebral infarction | End-stage renal disease | Stroke | Glucagon | Diabetes mellitus | Patients | Risk factors | Clinical outcomes | Glomerular filtration rate | Death | Diabetes | Kidney diseases | Cardiovascular diseases | Drug therapy | Glucagon-like peptide 1 | Long-term effects | Kidney transplantation | Index Medicus | Abridged Index Medicus
Journal Article